Cohen's review rests on a striking paradox: SLE T cells express HLA-DR/DP activation markers in vivo yet respond poorly to mitogens, antigens, and IL-2 generation in vitro, while B cells show spontaneous polyclonal activation but autoantibodies elevated thousands-fold over normal responses to foreign antigens — arguing against simple over-activation . Somatic mutation in an IgG anti-DNA antibody and epitope spreading on Sm support an antigen-driven mechanism — the review's most durable conclusion.
Peripheral-blood sampling may miss lesion-resident T cells (Cohen acknowledges this); immunosuppressive therapy confounds functional assays; all evidence is associative narrative synthesis without quantitative meta-analysis. Its antigen-processing hypothesis was speculative and explicitly flagged as lacking experimental basis — appropriately hedged .
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.